A confirmatory study of BBI-4000 gel in patients with primary axillary hyperhidrosis

The proportion of subjects achieving the primary endpoint was statistically significantly higher in the 5% group than in the 0% group (between-treatment difference: 17.5%, 95% confidence interval: 6.02-28.93, chi-square test: p = 0.003). All secondary endpoints showed improvement in the 5% group compared to the 0% group, with statistically significant differences between the treatment groups. Adverse events were generally mild, with no deaths, and no serious adverse events in the 5% group.